drug

Mini International Neuropsychiatric Interview

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by CHU de Reims
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder
NCT02834182—Unknown
Study on Communication Comprehension in the Schizophrenic Spectrum
NCT03225027—Completed

KOLs & investigators

2
Mouna TRABELSI, MD
Virginie BEAUCOUSIN, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
CHU de Reims
company
trial
fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder
NA
trial
Study on Communication Comprehension in the Schizophrenic Spectrum
NA
trial
indication
Schizophrenia
indication
Bipolar Disorder, Schizophrenia
indication
Bipolar Disorder
indication
Schizophrenia Simple
indication
KOL
Mouna TRABELSI, MD
KOL score —
person
Virginie BEAUCOUSIN, PhD
KOL score —
person